Skip to content
BLACK BOOK
manufacturer✓ Verified☎ Contact on file

Kyverna Therapeutics, Inc.

Biological Products, (No Diagnostic Substances) · Emeryville, CA, United States

  1. PrincipalsKaren Marie WalkerChief Technology OfficerMarc GrassoChief Financial OfficerMayobanex PujolsChief Technology Officerand 6 more
  2. CompanyKyverna Therapeutics, Inc.Emeryville, CA, United States
  3. Phone line+1 (510) 925-2492General business
Request a quote

Kyverna Therapeutics, Inc. is an SEC-registered Nasdaq-listed company (ticker KYTX) classified under SIC 2836: Biological Products, (No Diagnostic Substances).

Capabilities

✓ Pharmaceutical manufacturing
Evidence for each capability
  • Pharmaceutical manufacturing. SIC 2836 — Biological Products, (No Diagnostic Substances) — SEC EDGAR company submissions

People 9

Chief executive

Warner Weston BiddleChief Executive Officer

Chair & board

Andrew Craig MillerDirector (Board)
Beth C SeidenbergDirector (Board)
Christi ShawExecutive Chairperson
Sravan Kumar EmanyDirector (Board)

Finance

Marc GrassoChief Financial Officer

Technology & engineering

Karen Marie WalkerChief Technology Officer
Mayobanex PujolsChief Technology Officer
Everyone else on file (1)
Naji GehchanOfficer (see SEC filing)

Supplier profile

Production
Yes

Source timeline

  1. Record created from SEC EDGAR company submissions

    SEC EDGAR company submissions ↗
  2. Marc Grasso — Chief Financial Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  3. Warner Weston Biddle — Chief Executive Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  4. Mayobanex Pujols — Chief Technology Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  5. Karen Marie Walker — Chief Technology Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

Similar makers